$SHWZ
Medicine Man Technologies, Inc. Stock $shwz

$shwz Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000155837023004949 Filed on March 29, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$40.00M	$40.15M	$159.4M
YoY Change	25.88%	51.41%	47.0%
Cost Of Revenue	$16.97M	$17.18M	$74.35M
YoY Change	-18.58%	19.5%	25.87%
Gross Profit	$23.03M	$22.97M	$85.03M
YoY Change	110.58%	89.18%	72.29%
Gross Profit Margin	57.58%	57.22%	53.35%
Selling, General & Admin	$10.22M	$17.46M	$29.40M
YoY Change	-35.05%	104.84%	-24.51%
% of Gross Profit	44.35%	76.03%	34.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.151M	$2.683M	$11.01M
YoY Change	142.1%	236.58%	28.4%
% of Gross Profit	26.71%	11.68%	12.95%
Operating Expenses	$17.38M	$17.46M	$72.17M
YoY Change	10.52%	104.84%	85.33%
Operating Profit	$5.650M	$5.506M	$12.85M
YoY Change	-217.94%	52.27%	23.5%
Interest Expense	$757.7K	-$16.51M	-$11.76M
YoY Change	-103.66%	-242.22%	-242.36%
% of Operating Profit	13.41%	-299.92%	-91.52%
Other Income/Expense, Net	$757.6K	$3.740K	-$16.42M
YoY Change	7576370.0%
Pretax Income	$6.408M	-$23.70M	-$3.570M
YoY Change	-125.11%	-255.64%	-118.87%
Income Tax	$4.662M	$3.639M	$14.90M
% Of Pretax Income	72.76%
Net Earnings	$1.745M	-$29.85M	-$18.47M
YoY Change	-106.52%	-332.64%	-227.2%
Net Earnings / Revenue	4.36%	-74.35%	-11.59%
Basic Earnings Per Share	-$0.01		-$0.49
Diluted Earnings Per Share	-$0.06	-$0.48	-$0.49
COMMON SHARES
Basic Shares Outstanding	55.21M	54.74M	53.64M
Diluted Shares Outstanding	101.6M		53.64M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.62M	$39.40M	$39.40M
YoY Change	-25.3%	-62.97%	-62.97%
Cash & Equivalents	$35.17M	$38.95M	$38.95M
Short-Term Investments	$456.1K	$454.3K	$454.3K
Other Short-Term Assets	$8.330M	$5.293M	$5.293M
YoY Change	176.9%	74.23%	109.79%
Inventory	$25.58M	$22.55M	$22.55M
Prepaid Expenses
Receivables	$4.590M	$4.472M	$4.472M
Other Receivables	$0.00	$11.94K	$11.94K
Total Short-Term Assets	$74.12M	$71.74M	$71.74M
YoY Change	3.84%	-42.11%	-42.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.33M	$27.09M	$45.29M
YoY Change	-3.27%	164.2%	141.35%
Goodwill	$64.48M	$94.61M
YoY Change	-45.68%	118.41%
Intangibles	$132.4M	$107.7M
YoY Change		10.4%
Long-Term Investments	$2.000M	$2.000M	$2.000M
YoY Change	312.37%	305.23%	305.23%
Other Assets	$1.167M	$1.527M	$1.527M
YoY Change	-130.58%	196.58%	196.58%
Total Long-Term Assets	$249.3M	$251.1M	$251.1M
YoY Change	1.07%	55.88%	55.88%
TOTAL ASSETS
Total Short-Term Assets	$74.12M	$71.74M	$71.74M
Total Long-Term Assets	$249.3M	$251.1M	$251.1M
Total Assets	$323.4M	$322.9M	$322.9M
YoY Change	1.69%	13.28%	13.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.259M	$7.849M	$7.871M
YoY Change	32.8%	207.92%	204.4%
Accrued Expenses	$10.41M	$10.31M	$8.073M
YoY Change	930.43%	84.45%	2579.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$3.000M	$2.250M	$2.250M
YoY Change
Total Short-Term Liabilities	$41.97M	$47.38M	$47.38M
YoY Change	-40.28%	4.68%	4.68%
LONG-TERM LIABILITIES
Long-Term Debt	$128.2M	$125.5M	$125.5M
YoY Change	8.76%	28.76%	28.76%
Other Long-Term Liabilities	$19.11M	$17.31M	$17.31M
YoY Change	35.69%	98.66%	98.66%
Total Long-Term Liabilities	$147.3M	$143.3M	$142.8M
YoY Change	11.63%	34.97%	34.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$41.97M	$47.38M	$47.38M
Total Long-Term Liabilities	$147.3M	$143.3M	$142.8M
Total Liabilities	$189.3M	$190.7M	$190.7M
YoY Change	-6.41%	25.92%	25.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$44.50M	-$46.24M
YoY Change		66.49%
Common Stock	$56.35K	$56.35K
YoY Change		23.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.033M	$2.033M
YoY Change		34.02%
Treasury Stock Shares
Shareholders Equity	$134.1M	$132.2M	$132.2M
YoY Change
Total Liabilities & Shareholders Equity	$323.4M	$322.9M	$322.9M
YoY Change	1.69%	13.28%	13.28%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$1.745M	-$29.85M	-$18.47M
YoY Change	-106.52%	-332.64%	-227.2%
Depreciation, Depletion And Amortization	$6.151M	$2.683M	$11.01M
YoY Change	142.1%	236.58%	28.4%
Cash From Operating Activities	-$879.9K	$15.31M	$11.36M
YoY Change	-115.09%	-70.84%	-80.19%
INVESTING ACTIVITIES
Capital Expenditures	$2.913M	$2.302M	$14.81M
YoY Change	-211.73%	-230.16%	-361.36%
Acquisitions
YoY Change
Other Investing Activities	$10.63K	$28.24M	-$64.37M
YoY Change	-100.01%	-852.75%	-14.74%
Cash From Investing Activities	-$2.903M	$25.93M	-$79.18M
YoY Change	-96.88%	-569.86%	-2.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$511.4K
YoY Change			-98.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-41.02M	376.9K
YoY Change		-207.29%	-99.71%
NET CHANGE
Cash From Operating Activities	-879.9K	15.31M	11.36M
Cash From Investing Activities	-2.903M	25.93M	-79.18M
Cash From Financing Activities		-41.02M	376.9K
Net Change In Cash	-3.783M	224.1K	-67.45M
YoY Change	-93.56%	-99.74%	-164.14%
FREE CASH FLOW
Cash From Operating Activities	-$879.9K	$15.31M	$11.36M
Capital Expenditures	$2.913M	$2.302M	$14.81M
Free Cash Flow	-$3.793M	$13.01M	-$3.457M
YoY Change	-144.95%	-76.03%	-105.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001622879
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#GainLossOnSaleOfBusiness
CY2022	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#GainLossOnSaleOfBusiness
CY2022Q4	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent
CY2021Q4	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Recurring Basis Still Held Unrealized Gain Loss Statement Of Income Extensible List FairValueNetDerivativeAssetLiabilityRecurringBasisStillHeldUnrealizedGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#UnrealizedGainLossOnDerivatives
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-55450
CY2022	dei	Entity Registrant Name EntityRegistrantName	MEDICINE MAN TECHNOLOGIES, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-5289499
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	4880 Havana Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 201
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80239
CY2022	dei	City Area Code CityAreaCode	(303)
CY2022	dei	Local Phone Number LocalPhoneNumber	371-0387
CY2022	dei	Security12g Title Security12gTitle	Common Stock, $0.001 par value per share
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	50800000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55212547
CY2022	dei	Auditor Firm AuditorFirmId	5041
CY2022	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2022	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38949253
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	106400216
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4471978
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3866828
CY2022Q4	us-gaap	Inventory Net InventoryNet	22554182
CY2021Q4	us-gaap	Inventory Net InventoryNet	11121997
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	11944
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	39270
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	216771
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	454283
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	493553
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5293393
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2523214
CY2022Q4	us-gaap	Assets Current AssetsCurrent	71735033
CY2021Q4	us-gaap	Assets Current AssetsCurrent	124405808
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4899977
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1988973
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27089026
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10253226
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	2000000
CY2022Q4	us-gaap	Goodwill Goodwill	94605301
CY2021Q4	us-gaap	Goodwill Goodwill	43316267
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16290862
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7652750
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	107726718
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	97582330
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	143333
CY2021Q4	us-gaap	Nontrade Receivables Noncurrent NontradeReceivablesNoncurrent	303086
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1527256
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	514962
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18199399
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8511780
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	251147700
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	160624984
CY2022Q4	us-gaap	Assets Assets	322882733
CY2021Q4	us-gaap	Assets Assets	285030792
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7848613
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2548885
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	22380
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	36820
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10314958
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5592222
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	16508253
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	34923013
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	134498
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3139289
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2250000
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	7297815
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2027741
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	47381308
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45263179
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	125521520
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	97482468
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17314464
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8715480
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	502070
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	143338054
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	106197948
CY2022Q4	us-gaap	Liabilities Liabilities	190719362
CY2021Q4	us-gaap	Liabilities Liabilities	151461127
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	86994
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	86994
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	86050
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	82594
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	87
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	87
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56352545
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55212547
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45484314
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44745870
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	56353
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	45485
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	180381641
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	162815097
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46241583
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27773968
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	920150
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	517044
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2033127
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1517036
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	132163371
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	133569665
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	322882733
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	285030792
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	159379219
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	108420239
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	74349421
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	59066545
CY2022	us-gaap	Gross Profit GrossProfit	85029798
CY2021	us-gaap	Gross Profit GrossProfit	49353694
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	29398324
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16616306
CY2022	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	6722554
CY2021	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	5346934
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8011405
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	25369968
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	11943409
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2672713
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5037879
CY2022	us-gaap	Operating Expenses OperatingExpenses	72174964
CY2021	us-gaap	Operating Expenses OperatingExpenses	38944528
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	12854834
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	10409166
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-30139645
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-7014279
CY2022	shwz	Gain On Forfeiture Of Contingent Consideration GainOnForfeitureOfContingentConsideration	0
CY2021	shwz	Gain On Forfeiture Of Contingent Consideration GainOnForfeitureOfContingentConsideration	0
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	18414760
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	15061142
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	24136
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-4684366
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0
CY2021	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	242494
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-39270
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	216771
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16424385
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8506128
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3569551
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18915294
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14898064
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4396164
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-18467615
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14519130
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7802809
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	7346153
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26270424
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7172977
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53637003
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43339092
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53637003
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101368958
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26270424
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7172977
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	41774859
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14519130
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	22744003
CY2021	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	621272
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	49688600
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	271999
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	184536
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	4134338
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	133569665
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	133569665
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-18467615
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	15737855
CY2022	shwz	Return Of Common Stock As Compensation To Employee Officers And Or Directors ReturnOfCommonStockAsCompensationToEmployeeOfficersAndOrDirectors	1027288
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	516091
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	812269
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	132163371
CY2022	us-gaap	Profit Loss ProfitLoss	-18467615
CY2021	us-gaap	Profit Loss ProfitLoss	14519130
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11012453
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8576865
CY2022	shwz	Non Cash Interest Expenses NonCashInterestExpenses	4118391
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	8011405
CY2022	shwz	Noncash Lease Expense NoncashLeaseExpense	975561
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2712010
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4684369
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	18414760
CY2021	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	15061142
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1686049
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7484613
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-39270
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	216771
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	242494
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	812073
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5037879
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-467692
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-244929
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-789399
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4703186
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2631612
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1909014
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1009794
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	457083
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1075093
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	137139
CY2022	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	8165861
CY2021	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	493719
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-50000
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5270074
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2027741
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11356512
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8397712
CY2021	us-gaap	Proceeds From Collection Of Finance Receivables ProceedsFromCollectionOfFinanceReceivables	181911
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	62371226
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	75678000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14813145
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5638085
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	29580
CY2022	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	2000000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-79184371
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-81163754
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	132517383
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-134498
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-4865502
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	511393
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50283142
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	376895
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	177935023
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-67450964
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	105168981
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106400216
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1231235
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38949253
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106400216
CY2022	us-gaap	Interest Paid Net InterestPaidNet	15423990
CY2021	us-gaap	Interest Paid Net InterestPaidNet	5759220
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12340000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2100000
CY2022	shwz	Settling Of Note Receivable In Exchange For Equipment SettlingOfNoteReceivableInExchangeForEquipment	131389
CY2022	shwz	Issuance Of Debt For Acquisition IssuanceOfDebtForAcquisition	17000000
CY2022	shwz	Return Of Common Stock ReturnOfCommonStock	555010
CY2021	shwz	Return Of Common Stock ReturnOfCommonStock	184536
CY2022	shwz	Issuance Of Stock As Payment For Acquisitions IssuanceOfStockAsPaymentForAcquisitions	15777373
CY2021	shwz	Issuance Of Stock As Payment For Acquisitions IssuanceOfStockAsPaymentForAcquisitions	22744003
CY2022	shwz	Deferred Tax Liability From Acquisition DeferredTaxLiabilityFromAcquisition	-3214080
CY2021	shwz	Issuance Of Preferred Stock In Connection With Private Or Public Offerings IssuanceOfPreferredStockInConnectionWithPrivateOrPublicOfferings	49688553
CY2021	shwz	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	272000
CY2022	shwz	Noncash Or Part Noncash Acquisition Tangible And Intangible Assets Acquired Net Of Cash NoncashOrPartNoncashAcquisitionTangibleAndIntangibleAssetsAcquiredNetOfCash	34402043
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	1837221
CY2022	shwz	Noncash Or Part Noncash Acquisition Goodwill Acquired NoncashOrPartNoncashAcquisitionGoodwillAcquired	62368339
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2022Q4	us-gaap	Investments Investments	2000000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><i style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.</p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;"><i style="text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on net earnings and financial position. In accordance with ASC 230 <i style="font-style:italic;">Statement of Cash Flows,</i> the Company updated its 2021 statement of cash flows presentation to reflect cash proceeds from financing and the change in the derivative from the valuation date. This change had no impact on net earnings and financial position.</p>
CY2021Q4	us-gaap	Investments Investments	0
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38949253
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	106400216
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	92940
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	135046
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	4471978
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	4169914
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	62368339
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	640001
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	11719306
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	6820649
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3038176
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3881627
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	1527256
CY2022Q4	shwz	Prepaid Inventory Current And Noncurrent PrepaidInventoryCurrentAndNoncurrent	1411766
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	1587770
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	514962
CY2021Q4	shwz	Prepaid Inventory Current And Noncurrent PrepaidInventoryCurrentAndNoncurrent	935444
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	7910511
CY2021Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	2585705
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	10314958
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5592222
CY2022Q4	us-gaap	Goodwill Goodwill	94605301
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	11719306
CY2020Q4	us-gaap	Goodwill Goodwill	53046729
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	17681639
CY2022Q4	shwz	Loyalty Liability LoyaltyLiability	1590346
CY2021Q4	shwz	Loyalty Liability LoyaltyLiability	1485224
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2369223
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	971419
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2672713
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5037879
CY2021	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-27412101
CY2021Q4	us-gaap	Goodwill Goodwill	43316267
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4658775
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	124017580
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2325482
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	12676
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	14504490
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5535992
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5724210
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5573329
CY2022Q4	us-gaap	Inventory Net InventoryNet	22554182
CY2021Q4	us-gaap	Inventory Net InventoryNet	11121997
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31989003
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12242199
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4899977
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1988973
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27089026
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10253226
CY2022	us-gaap	Depreciation Depreciation	2911004
CY2021	us-gaap	Depreciation Depreciation	1124571
CY2021Q4	us-gaap	Goodwill Goodwill	43316267
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16290862
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	105235080
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7652750
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	8638112
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7452294
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	875400
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2021	shwz	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	true
CY2022	shwz	Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	true
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9842054
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9520667
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9412888
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	8638056
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	8330329
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	61982724
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	107726718
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	34923013
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-18414760
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	16508253
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	18414760
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	14013661
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7484613
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	458885
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	6603695
CY2021Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8289743
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	40993176
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	48477789
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	127771520
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	97482468
CY2022Q4	shwz	Less Current Portion Of Long Term Debt LessCurrentPortionOfLongTermDebt	-2250000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	125521520
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	97482468
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2250000
CY2022Q4	shwz	Long Term Debt Unamortized Debt Issuance Costs Year Two LongTermDebtUnamortizedDebtIssuanceCostsYearTwo	1686049
CY2022Q4	shwz	Long Term Debt Unamortized Debt Discount Year Two LongTermDebtUnamortizedDebtDiscountYearTwo	8523493
CY2022Q4	shwz	Total Long Term Debt Year Two TotalLongTermDebtYearTwo	-7959542
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3000000
CY2022Q4	shwz	Long Term Debt Unamortized Debt Issuance Costs Year Three LongTermDebtUnamortizedDebtIssuanceCostsYearThree	1686049
CY2022Q4	shwz	Long Term Debt Unamortized Debt Discount Year Three LongTermDebtUnamortizedDebtDiscountYearThree	9734935
CY2022Q4	shwz	Total Long Term Debt Year Three TotalLongTermDebtYearThree	-8420984
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	40651759
CY2022Q4	shwz	Long Term Debt Unamortized Debt Issuance Costs Year Four LongTermDebtUnamortizedDebtIssuanceCostsYearFour	1686049
CY2022Q4	shwz	Long Term Debt Unamortized Debt Discount Year Four LongTermDebtUnamortizedDebtDiscountYearFour	11057799
CY2022Q4	shwz	Total Long Term Debt Year Four TotalLongTermDebtYearFour	27907911
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	129466632
CY2022Q4	shwz	Long Term Debt Unamortized Debt Issuance Costs Year Five LongTermDebtUnamortizedDebtIssuanceCostsYearFive	1545548
CY2022Q4	shwz	Long Term Debt Unamortized Debt Discount Year Five LongTermDebtUnamortizedDebtDiscountYearFive	11676949
CY2022Q4	shwz	Total Long Term Debt Year Five TotalLongTermDebtYearFive	116244135
CY2022Q4	shwz	Long Term Debt Maturities Repayments Of Principal LongTermDebtMaturitiesRepaymentsOfPrincipal	175368391
CY2022Q4	shwz	Long Term Debt Unamortized Debt Issuance Costs LongTermDebtUnamortizedDebtIssuanceCosts	6603695
CY2022Q4	shwz	Long Term Debt Unamortized Debt Discount LongTermDebtUnamortizedDebtDiscount	40993176
CY2022Q4	shwz	Total Long Term Debt TotalLongTermDebt	127771520
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18199399
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3139289
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17314464
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	84325
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2359197
CY2022Q4	shwz	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1705867
CY2021Q4	shwz	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	861683
CY2022Q4	shwz	Lessee Operating Lease Liability Payments Due Next Twelve Months1 LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths1	33595944
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	13298212
CY2022Q4	shwz	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	20297732
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	5873512
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	5032891
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	4692760
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	4204171
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	2923785
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	10868825
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	33595944
CY2022	shwz	Number Of Classes Of Stock NumberOfClassesOfStock	2
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	86994
CY2022Q4	shwz	Escrow Shares EscrowShares	944
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	86994
CY2021Q4	shwz	Escrow Shares EscrowShares	4428
CY2022	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.08
CY2022	us-gaap	Preferred Stock Dividend Rate Per Dollar Amount PreferredStockDividendRatePerDollarAmount	1000
CY2022Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	1.20
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7802809
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	7346153
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56352545
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55212547
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	920150
CY2022	shwz	Common Stock Held In Escrow CommonStockHeldInEscrow	219848
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	45484314
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	44745870
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	517044
CY2021	shwz	Common Stock Held In Escrow CommonStockHeldInEscrow	221400
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	598861
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2518158
CY2022Q4	shwz	Deferred Tax Assets Loyalty Points DeferredTaxAssetsLoyaltyPoints	412218
CY2021Q4	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	272
CY2021Q4	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	245017
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-18467615
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14519130
CY2022	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	7802809
CY2021	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	7346153
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26270424
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7172977
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53637003
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43339092
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26270424
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7172977
CY2021	shwz	Add Investor Note Accrued Interest AddInvestorNoteAccruedInterest	789028
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	458885
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-14013661
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-26270424
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5592771
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53637003
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43339092
CY2021	shwz	Dilutive Effect Of Investor Notes DilutiveEffectOfInvestorNotes	51748797
CY2021	shwz	Dilutive Effect Of Warrants DilutiveEffectOfWarrants	2581250
CY2021	shwz	Dilutive Effect Of Options DilutiveEffectOfOptions	3699819
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53637003
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101368958
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2021Q4	shwz	Deferred Tax Assets Loyalty Points DeferredTaxAssetsLoyaltyPoints	363171
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	367776
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	217320
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	662861
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	36742
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	94620
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	8537
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	9099
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6836457
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	17127037
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	4284163
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	483037
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	112001
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	17610074
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4396164
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-611750
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2100260
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2712010
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3569552
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5360518
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-749606
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1125709
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-949986
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	293358
CY2022	shwz	Effective Income Tax Rate Reconciliation Nondeductible Expense Expenses Under Irc Section280 E Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExpensesUnderIrcSection280EAmount	16308522
CY2021	shwz	Effective Income Tax Rate Reconciliation Nondeductible Expense Expenses Under Irc Section280 E Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExpensesUnderIrcSection280EAmount	5610279
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	177912
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	578692
CY2022	shwz	Effective Income Tax Rate Reconciliation Derivative Liability Remeasurement Amount EffectiveIncomeTaxRateReconciliationDerivativeLiabilityRemeasurementAmount	-3867100
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	244130
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	28918
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2062697
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5170426
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-176568
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-181521
CY2022	shwz	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	4890722
CY2021	shwz	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	416125
CY2022	shwz	Effective Income Tax Rate Reconciliation Deferred Tax True Up Amount EffectiveIncomeTaxRateReconciliationDeferredTaxTrueUpAmount	1082735
CY2021	shwz	Effective Income Tax Rate Reconciliation Deferred Tax True Up Amount EffectiveIncomeTaxRateReconciliationDeferredTaxTrueUpAmount	1695030
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14898064
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4396164
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	64858
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	1129939
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2062697
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6836457
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2596078
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	63301
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	5594714
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1568542
CY2022Q4	shwz	Deferred Tax Liabilities Operatingleases DeferredTaxLiabilitiesOperatingleases	1595394
CY2021Q4	shwz	Deferred Tax Liabilities Operatingleases DeferredTaxLiabilitiesOperatingleases	850793
CY2022Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	117750
CY2021Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	55576
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	30669
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	57866
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7338527
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2596078
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	502070
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2062697
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001558370-23-004949-index-headers.html	Edgar Link	pending
0001558370-23-004949-index.html	Edgar Link	pending
0001558370-23-004949.txt	Edgar Link	pending
0001558370-23-004949-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
shwz-20221231.xsd	Edgar Link	pending
shwz-20221231x10k.htm	Edgar Link	pending
shwz-20221231xex10d28.htm	Edgar Link	pending
shwz-20221231xex10d29.htm	Edgar Link	pending
shwz-20221231xex10d41.htm	Edgar Link	pending
shwz-20221231xex21d1.htm	Edgar Link	pending
shwz-20221231xex23d1.htm	Edgar Link	pending
shwz-20221231xex2d34.htm	Edgar Link	pending
shwz-20221231xex2d36.htm	Edgar Link	pending
shwz-20221231xex31d1.htm	Edgar Link	pending
shwz-20221231xex31d2.htm	Edgar Link	pending
shwz-20221231xex32d1.htm	Edgar Link	pending
shwz-20221231xex4d1.htm	Edgar Link	pending
shwz-20221231_lab.xml	Edgar Link	unprocessable
shwz-20221231_cal.xml	Edgar Link	unprocessable
shwz-20221231_def.xml	Edgar Link	unprocessable
shwz-20221231_pre.xml	Edgar Link	unprocessable
shwz-20221231x10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHWZ
Medicine Man Technologies, Inc. Stock $shwz

2023 Q1 Form 10-K Financial Statement

#000155837023004949 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHWZ Medicine Man Technologies, Inc. Stock $shwz

2023 Q1 Form 10-K Financial Statement

#000155837023004949 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHWZ
Medicine Man Technologies, Inc. Stock $shwz